Meet Rousselot at 4th CRIG. At our booth, you will have the chance to meet Bjorn Vergauwen, Scientific Director Gelatin and Sander Lybaert, responsible for Business Development and technical Support at Rousselot. Be prepared to engage in substantive discussions and learn more about our expertise in gelatin-based solutions, particularly our innovative product line, X-Pure®.

Rousselot's biomedical segment is committed to enhancing patients' lives by delivering ultra-pure gelatins produced under stringent quality control standards. X-Pure offers customized and modified gelatins tailored to specific application requirements. Our focus extends beyond medical-grade gelatins, encompassing applications in drug delivery, diagnostics, and more.

Rousselot at the 4th CRIG

During our presentation titled "Rousselot Biomedical: Innovating Gelatin-Based Solutions for Drug Delivery," scheduled for the session from 14:00 to 15:20, we will explore the possibilities that X-Pure gelatins offer in the application of drug delivery. Gelatin is well known to the industry and has a record of safe use in plasma volume extenders and live attenuated vaccins for over 100 years. In our presentation we will highlight new developments in the field of advanced drug delivery. We will dive into the opportunities of gelatin precise, slow-release, and localized drug delivery through injectable hydrogels, hydrogel implants, microneedles, and drug-eluting coatings.

Our aim is not only to discuss but to provide practical solutions for enterprises facing challenges in drug delivery.

Additionally, in the field of cancer diagnostics and the development of 3D cell culture models, the importance of low-endotoxin gelatin cannot be overstated. Endotoxins can disrupt the microenvironment, impacting diagnostic assays and cell culture models. Rousselot addresses these critical issues by offering low-endotoxin gelatins.

Our participation in the 4th CRIG Industrial Partnering Event underscores our commitment to advancing the field of gelatin-based solutions. We eagerly anticipate engaging with fellow industry professionals, researchers, and stakeholders. We invite everyone to visit our booth and attend our presentation to learn more about how Rousselot is contributing to innovation in the field of drug delivery and biomedical solutions.